M. Chadi Alraies, ESC 2018 – End-stage Renal Disease (ESRD) and Peripheral Intervention
Dr M. Chadi Alraies (Wayne State University, Detroit Medical Center, Detroit, MI, USA) discusses the background, rationale and results of end-stage renal disease (ESRD) and peripheral intervention trial, presented at ESC 2018.
Filmed at ESC 2018, Munich.
View more content here.
Speaker Disclosure: Dr M. Chadi Alraies has nothing to disclose in relation to this video interview.
1. What was the background of the trial into end-stage renal disease (ESRD) and peripheral intervention? (0:08)
2. What were the key results of the trial? (0:49)
3. What are the next steps for this area of research? (1:41)
4. What are your highlights from this year’s ESC meeting? (2:25)
touchCARDIO.com is an independent information resource supporting physicians, clinicians and leading industry professionals in continuously developing their knowledge, effectiveness and productivity, via open-access content in multimedia formats.
Share this Video
Related Videos In Interventional Cardiology
Gregg Stone, ACC 2023: Transcatheter edge-to-edge repair for functional mitral regurgitation in heart failure
Transcatheter edge-to-edge repair (TEER) is a minimally invasive procedure that can effectively treat functional mitral regurgitation in heart failure patients. Compared to traditional surgical approaches, TEER offers benefits such as reduced hospital stay, lower risk of bleeding and infection, and faster recovery time. Additionally, TEER has been found to improve symptoms and quality of life […]
Gregg Stone, ACC 2023: COAPT trial results – Transcatheter edge-to-edge repair with MitraClip device for functional mitral regurgitation in heart failure
The COAPT trial investigated the use of the MitraClip a novel device for patients with secondary mitral regurgitation, a condition in which blood leaks backward through the mitral valve into the left atrium of the heart. In this touchCARDIO interview Dr Gregg Stone (Mount Sinai Heart Health System, New York City, NY, USA) discusses the […]
Hyo-Soo Kim, ACC 2023: Guidelines for the use of short-term dual antiplatelet therapy after coronary intervention
The guidelines for the use of short-term dual antiplatelet therapy (DAPT) after coronary intervention vary depending on the patient’s clinical situation and the type of intervention performed. In this touchCARDIO interview, we speak with Prof. Hyo-Soo Kim (Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea) to discuss the current guidelines for the […]
Journal articles and more to your inbox
Get the latest clinical insights from touchCARDIOSign me up!